Michael Des Jardin

Title: Michael Des Jardin: Innovator in Pharmaceutical Compositions

Introduction

Michael Des Jardin is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of pharmaceuticals. With a focus on benzodiazepine compositions, he has developed innovative methods for intranasal administration that aim to improve treatment outcomes for various disorders.

Latest Patents

Des Jardin holds two patents, both centered around pharmaceutical compositions of clonazepam and other benzodiazepines. His latest inventions include formulations designed for intranasal administration, utilizing a binary solvent system. This system comprises a first solvent that effectively penetrates nasal mucosal tissue and a second solvent in which the benzodiazepine is less soluble. These compositions are intended to treat a range of disorders, including panic attacks, muscle spasms, anxiety, and seizures. Notably, one of his inventions focuses on a fast-acting clonazepam composition for the treatment of seizure clusters.

Career Highlights

Michael Des Jardin is currently associated with Jazz Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has the potential to enhance the efficacy of treatments for patients suffering from various neurological and psychological conditions.

Collaborations

Des Jardin has collaborated with notable colleagues, including Gene Curtis Jamieson and Clark Patrick Allphin, contributing to a dynamic and innovative work environment.

Conclusion

Michael Des Jardin's contributions to pharmaceutical compositions reflect his commitment to improving patient care through innovative solutions. His work in developing intranasal formulations for benzodiazepines showcases the potential for advancements in the treatment of complex disorders.